← Insider Monitor
VERACYTE, INC. logo
VCYT

VERACYTE, INC.

Nasdaq · Services-Medical Laboratories

10
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

Veracyte develops genomic tests that analyze tissue, blood, or other samples to help diagnose diseases such as thyroid, lung, and breast cancer, giving physicians information to guide treatment decisions and reduce unnecessary surgeries.

Industry
Services-Medical Laboratories
Headquarters
South San Francisco, CA
Exchange
Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
EASTHAM KARINDirectorSell$743KOct 27, 2026
Holstein JensDirectorSell$353KSep 24, 2026
Holstein JensDirectorSell$375KOct 27, 2026
Bhanji MunaDirectorSell$81KOct 19, 2026
Chambers RebeccaChief Financial OfficerSell$51KSep 4, 2026
Febbo Phillip G.Chief Scientific & Med OfficerSell$446KSep 4, 2026
McGuire AnnieEVP, General CounselSell$48KSep 4, 2026
Febbo Phillip G.Chief Scientific & Med OfficerSell$118KSep 4, 2026
Chambers RebeccaChief Financial OfficerSell$106KSep 4, 2026
McGuire AnnieEVP, General CounselSell$92KSep 4, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for VCYT.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable VCYT activity by email

Free alerts for the insider and congressional trades worth watching.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.